| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-8703(91)90859-G |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000287039190859G?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:000287039190859G?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1824652 |
| P2093 | author name string | S. H. Taylor | |
| P2860 | cites work | Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers | Q28334510 |
| Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers | Q33509120 | ||
| Doxazosin therapy in the treatment of diabetic hypertension | Q37080367 | ||
| Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study | Q37897616 | ||
| Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction | Q39471437 | ||
| Coronary artery disease risk factor management in the hypertensive patient | Q39657297 | ||
| Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients | Q40074815 | ||
| The relationship between post-load plasma glucose and blood pressure at different resting heart rates | Q41500035 | ||
| Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension | Q42127517 | ||
| Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol | Q42620274 | ||
| Insulin and blood pressure in obesity | Q43612222 | ||
| Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients. | Q52426199 | ||
| A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus. | Q52426201 | ||
| Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency. | Q52426203 | ||
| Clinical experience with doxazosin in general medical practice. | Q52426205 | ||
| Coronary risk prediction in adults (the Framingham Heart Study) | Q52596211 | ||
| A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication | Q62255610 | ||
| Doxazosin in the treatment of mild or moderate essential hypertension: An echocardiographic study | Q67897246 | ||
| Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension | Q67897247 | ||
| Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicenter Study Group | Q67898313 | ||
| Mortality in patients of the Glasgow Blood Pressure Clinic | Q69518462 | ||
| Hypertension. Relationship with other risk factors | Q69544998 | ||
| Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension | Q69900515 | ||
| A multicenter study of doxazosin in the treatment of severe essential hypertension | Q69928258 | ||
| Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma | Q69928261 | ||
| P433 | issue | 1 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cardiology and cardiovascular medicine | Q96320350 |
| P304 | page(s) | 286-292 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Efficacy of doxazosin in specific hypertensive patient groups | |
| P478 | volume | 121 |
| Q81238665 | Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning |
| Q34314049 | Peripheral vascular disease and hypertension: a forgotten association? |
Search more.